| Issuer | % of Class | Filed |
|---|---|---|
|
Addex Therapeutics Ltd.
13D/A
Amendment 10
ADXN · 00654J206
|
9.0% |
9/4/2026
Event 9/2/2026
|
|
Addex Therapeutics Ltd.
13D/A
Amendment 9
ADXN · 00654J206
|
9.0% |
8/27/2026
Event 8/26/2026
|
|
Addex Therapeutics Ltd.
13D/A
Amendment 8
ADXN · 00654J206
|
12.9% |
6/23/2025
Event 6/20/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.